课题基金 / 基金详情

The Presenilins as G-Protein Coupled Receptors

The Presenilins as G-Protein Coupled Receptors
作为 G 蛋白偶联受体的早老素
批准号:
7799873
负责人:
NAZNEEN N DEWJI
金额:
$33.46万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-15 至 2012-03-31

项目摘要

项目成果

NAZNEEN N DEWJI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):作为G蛋白偶联受体的早老素我们关于早老素(PS)的7-TM结构的证据(1,2)使我们怀疑PS-1和PS- 2是否属于蛋白质的GPCR超家族,这两种蛋白质基本上都具有相似的结构。其他人以前的工作(3)已经表明PS-1激活G蛋白,尽管这些发现被忽略了,可能是因为早老蛋白的8-TM结构在过去几年中几乎被该领域普遍接受。我们的假设是,在这样一个系统中,PS的激活将导致G蛋白结合,这在其他系统中,调节许多下游信号事件。因此,对PS-1和PS-2的GPCR功能的调节可能对阿尔茨海默病产生影响。我们的具体目标如下:1.进一步确认和扩展G蛋白与PS-1和PS-2结合的分子细节(后者以前没有研究过)。2.研究PS-1和PS-2的GPCR功能是否调节阿尔茨海默病细胞中经常受到干扰的Ca 2+稳态。3.研究膜结合的B-APP作为PS-1和PS-2的特异性配体调节其GPCR活性的可能作用,既与正常细胞生理学有关,又与阿尔茨海默病病因学相关的机制有关。与公共卫生的相关性:对阿尔茨海默病的意义:如果我们提出的研究阐明早老素:G-蛋白偶联确实对PS介导阿尔茨海默病中Ca 2+稳态的机制具有重要意义,或者/并且他们表明<$-APP是特异性激活PS-Go偶联的配体,那么这些研究的可能结果可能是使用适当设计的PS-Go特异性结合抑制剂对阿尔茨海默病进行药物治疗。
英文摘要
DESCRIPTION (provided by applicant): THE PRESENILINS AS G-PROTEIN COUPLED RECEPTORS Our evidence (1,2) for a 7-TM structure for the Presenilins (PS) has led us to question whether PS-1 and PS- 2 belong to the GPCR superfamily of proteins, which all share essentially a similar structure. Previous work by others (3) has shown G-protein activation by PS-1, although these findings have been ignored, presumably because the 8-TM structure of the presenilins has been nearly universally accepted by the field over the last several years. Our hypothesis is that in such a system, the activation of PS would lead to G- protein binding, which in other systems, modulates many downstream signaling events. Regulation of the proposed GPCR function of PS-1 and PS-2 may therefore have consequences for Alzheimer's disease. Our specific aims are as follows: 1. To further confirm and extend the molecular details of G-protein binding to PS-1 and PS-2 (the latter not having been previously studied). 2. To investigate whether the GPCR function of PS-1 and PS-2 modulates the Ca2+ homeostasis that is frequently perturbed in the cell in Alzheimer's disease. 3. To investigate a possible role of membrane-bound B-APP as a specific ligand for PS-1 and PS-2 that regulates their GPCR activity, both in connection with normal cell physiology, and with the mechanisms involved in the etiology of Alzheimer's disease. Relevance to Public Health: Significance for Alzheimer's Disease: If our proposed studies elucidate Presenilin:G-protein coupling to indeed be significant to the mechanism by which PS mediates Ca2+ homeostasis in Alzheimer's disease, or/and they show that ¿-APP is the ligand that specifically activates PS-Go coupling, then a possible outcome of these studies might be a drug therapy for Alzheimer's disease using appropriately designed inhibitors of PS-Go specific binding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecule therapeutics for Alzheimer's Disease
  • 批准号:
    9253281
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2016
  • 负责人:
    NAZNEEN N DEWJI
  • 依托单位:
Small molecule therapeutics for Alzheimer's Disease
  • 批准号:
    9789134
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2016
  • 负责人:
    NAZNEEN N DEWJI
  • 依托单位:
Intranasal Delivery of Peptide Drugs to the Brain
  • 批准号:
    8394960
  • 项目类别:
  • 资助金额:
    $26.18万
  • 财政年份:
    2012
  • 负责人:
    NAZNEEN N DEWJI
  • 依托单位:
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease
  • 批准号:
    10157628
  • 项目类别:
  • 资助金额:
    $175.0万
  • 财政年份:
    2012
  • 负责人:
    NAZNEEN N DEWJI
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究